Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines. (Q40526445)
Jump to navigation
Jump to search
scientific article published on October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines. |
scientific article published on October 2004 |
Statements
Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines (English)
Sandra Huguenin
Jocelyne Fleury-Feith
Laurence Kheuang
Manlio Bolla
Jean-Pierre Riffaud
Dominique K Chopin
Francis Vacherot
1 reference
1 reference